Evidence map›Paper›PMID 27649122›Full record

ArticleMolecules (Basel, Switzerland)2016

Structural Elucidation of a Novel Polysaccharide from Pseudostellaria heterophylla and Stimulating Glucose Uptake in Cells and Distributing in Rats by Oral.

Jinlong Chen, Wensheng Pang, Wentao Shi, Bin Yang, Yongjun Kan, Zhaodong He, Juan Hu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. A Pectin Polysaccharide fromMolecules (Basel, Switzerland) · 2025
    Article
  2. Review
  3. Simulation ofFrontiers in plant science · 2024
    Article
  4. Extraction of Polysaccharides from Root ofMolecules (Basel, Switzerland) · 2023
    Article
  5. The regulatory effects ofFood science & nutrition · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Herbal Medicine, Gut Microbiota, and COVID-19.Frontiers in pharmacology · 2021
    Review
  12. Molecular therapy oncolytics · 2020
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jinlong ChenThe Institute of Drug Research, Fujian Academy of Traditional Chinese Medicine, Fuzhou 350003, China. hzf_ketizu@163.com.
Wensheng PangThe College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China. pws@fjtcm.edu.cn.
Wentao ShiThe College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China. 13860662716@163.com.
Bin YangThe College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China. 13905915817@163.com.
Yongjun KanThe Institute of Drug Research, Fujian Academy of Traditional Chinese Medicine, Fuzhou 350003, China. cld_ketizu@163.com.
Zhaodong HeThe Institute of Drug Research, Fujian Academy of Traditional Chinese Medicine, Fuzhou 350003, China. hzd_fjtcmyjy@163.com.
Juan HuThe Institute of Drug Research, Fujian Academy of Traditional Chinese Medicine, Fuzhou 350003, China. huj@fjtcm.edu.cn.
Fujian University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The semi-refined polysaccharide of Pseudostellaria heterophylla is a complex polysaccharide that exhibits significantly hypoglycemic activities. A novel homogeneous polysaccharide, named as H-1-2, was isolated from the semi-refined polysaccharide. The mean molecular weight of H-1-2 was 1.4 × 10⁴ Da and it was only composed of d-glucose monosaccharide. Structure elucidation indicated that H-1-2 contains pyranride, and has the characteristics of the α-iso-head configuration, a non-reducing end (T-), 4-, 1,6-, and 1,4,6-connection, in all four ways to connect glucose. H-1-2 was a type of glucan, where chemical combination exists in the main chain between 1→4 linked glucose, and contains a small amount of 1,6-linked glucose, which was in the branched chain. In vitro HepG2, 3T3-L1, and L6 cells were used to assess cellular glucose consumption and cellular glucose uptake by glucose oxidase, and the transport of 2-NBDG fluorescence probe results showed that H-1-2 could clearly increase glucose uptake and utilization in muscle and adipose cells, which is beneficial to screen for in the discovery of anti-diabetes lead compounds. H-1-2 was labeled with radioisotopes ((99m)Tc-pertechnetate). (99m)Tc-labeled-H-1-2 was performed by SPECT/CT analysis images after oral administration in rats. At 4 h post ingestion, about 50% of the radioactivity was observed in the intestine. No significant radioactivity was found in the heart, liver, and kidney, conjecturing that absorption of (99m)Tc-labeled H-1-2 might, via intestinal mucosa, be absorbed into systemic circulation. This problem, as to whether the polysaccharide is absorbed orally, will need further examination.

Indexed as

Hypoglycemic AgentsPolysaccharides3T3-L1 CellsAdministration, OralAnimalsCaryophyllaceaeGlucoseHep G2 CellsHumansIntestinal AbsorptionIntestinal MucosaMiceRatsGlucoseHypoglycemic AgentsPolysaccharidesa novel polysaccharidedistribution taken orallyglucose uptakePseudostellaria heterophyllastructure

Identifiers

PMID27649122
PMCPMC6272879
OpenAlexW2520126616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.